In summary, our findings indicate that several proinflammatory cytokines, namely, IL-2, IL-6, IL-8, IL-12, and IFN-γ, have potential as diagnostic biomarkers for distinguishing patients with MD from healthy individuals. This evidence concerns the gene IL2 and Menkes disease.